BioSpace News Archive

Drug Development

AI in Medical Field for Clinical Trials Increase, Refining Endpoints, Quantifying Pain, & More

Ai in medical field is helping the researchers at clinical stage research by increasing the efficiency, refining endpoints and quantifying pain, and much more.

September 4, 2020
·
4 min read
·
Gail Dutton
Drug Development

Moncef Slaoui Will Quit Operation Warp Speed if Politics Plays Role in Vaccine Approval

When Moncef Slaoui was tapped to helm Operation Warp Speed, he sought confirmation that politics would not play a role in driving certain treatments through an approval process without the proper supporting scientific data to back it up.

September 4, 2020
·
2 min read
·
Alex Keown
Business

The Sky Remains the Limit for AbbVie with New Collaborative Partnerships

AbbVie and I-Mab announced today that they had entered a global collaboration agreement to develop and commercialize lemzoparlimab (also known as TJC4). The anti-CD47 monoclonal antibody was initially discovered and developed by I-Mab for the treatment of various cancers.

September 4, 2020
·
3 min read
·
Krystle Vermes
BioForest

Panel Lays Out Gene Editing Guidelines, Condemns Risk of Creating ‘CRISPR’ Babies

Using gene therapy to edit embryos, sperm or eggs in order to improve health conditions in a child should not be conducted due to the unreliability of the science, as well as due to significant ethical and moral concerns.Those are the words found in new guidance established this week.

September 4, 2020
·
3 min read
·
Alex Keown
Biotech Bay

The Possibility of Simultaneous COVID-19 and Flu Infections Poses a Double-Threat

As we head into cold and flu season, the question arises: Can you get COVID-19 and the flu at the same time?

September 4, 2020
·
3 min read
·
Mark Terry
Drug Development

NanoViricides Outlines Two-Pronged Approach to Developing COVID-19 Therapies

NanoViricides, based in Shelton, Connecticut, outlined its approach to developing therapies against COVID-19 at the LD 500 investor conference yesterday.

September 4, 2020
·
3 min read
·
Mark Terry
Biotech Bay

Alarming Research Shows COVID-19 Damage to Heart Muscle, At Least in Cell Cultures

Researchers at San Francisco’s Gladstone Institutes published research on bioRxiv—which means it has not been peer-reviewed—that demonstrated, in culture, how the virus damages cardiac muscles.

September 4, 2020
·
3 min read
·
Mark Terry
Policy

Appeals Court Deals Blow to Patent Protections for Amarin’s Vascepa

Shares of Amarin Corporation are down more than 3% in premarket trading after the company reported Thursday that a panel of three judges from the U.S. Court of Appeals upheld a lower court’s ruling that paved the way for generic competition for the company’s heart disease drug, Vascepa.

September 4, 2020
·
2 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: August 31-September 4

It was a busy week for both COVID-19-related clinical trial news and the rest of the industry. Here’s a look.

September 4, 2020
·
9 min read
·
Mark Terry
Nippon Express USA Acquires GDP Certification for Chicago Warehouse

- NEX Pharma Solutions-Chicago Begins Operations as Temperature-controlled Facility for Handling Pharmaceuticals -

September 4, 2020
·
2 min read